Current Management of Hereditary Angioedema: Case Series

PROGRAM DESCRIPTION Hereditary angioedema (HAE) is a rare, potentially life-threatening disease caused by deficiency or dysfunction of C1 esterase inhibitor (C1-INH), a part of the complement system involved in inhibition ...

PROGRAM DESCRIPTION
Hereditary angioedema (HAE) is a rare, potentially life-threatening disease caused by deficiency or dysfunction of C1 esterase inhibitor (C1-INH), a part of the complement system involved in inhibition of swelling. Many of those most commonly reported symptoms of HAE (abdominal pain and swelling, swelling of extremities, and throat closure) overlap with conditions such as anaphylaxis, gastrointestinal disorders, acute surgical conditions, or acute pain conditions, making recognition of HAE very challenging. This, in turn, often leads to delays in diagnosis as well as inappropriate treatment. This program will utilize a case-based format to engage healthcare providers by linking discussion of the latest scientific data with its application in the clinical setting.

EDUCATIONAL OBJECTIVES
Upon completion of this educational activity, participants should be able to:Differentiate key signs and symptoms of HAE from other common conditions and review the diagnostic tests in HAEIdentify key considerations in development of individualized treatment plans for patients with HAE

---

Write the first review

Resource tags